Phase I trial of hAd5 T-cell vaccine
Latest Information Update: 22 Jan 2021
At a glance
- Drugs COVID-2019 vaccine-ImmunityBio (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 22 Jan 2021 New trial record
- 19 Jan 2021 According to an ImmunityBio media release, Dr. Amy Ward is the principal investigator and Dr. Graeme Meintjes is the co-investigator on this trial.
- 19 Jan 2021 According to an ImmunityBio media release, the company received authorization from the South Africa Health Products Regulatory Authority (SAHPRA) to begin this trial.